4 US IPOs planned for the week of Jul 30

By
A A A

The following IPOs are expected to price this week :

Eloqua ( ELOQ ), which provides on-demand software to automate marketing and sales initiatives, plans to raise $84 million by offering 8.0 million shares at a price range of $9.50 to $11.50. At the midpoint of the proposed range, Eloqua would command a market value of $401 million. Eloqua, which was founded in 1999, booked $85 million in sales over the last 12 months. The Vienna, VA-based company plans to list on the NASDAQ under the symbol ELOQ. J.P. Morgan and Deutsche Bank Securities are the joint bookrunners on the deal.

Globus Medical ( GMED ), which sells spine implants to hospitals for use in surgical procedures, plans to raise $200 million by offering 11.8 million shares at a price range of $16.00 to $18.00. At the midpoint of the proposed range, Globus Medical would command a market value of $1.6 billion. Globus Medical, which was founded in 2003, booked $348 million in sales over the last 12 months. The Audubon, PA-based company plans to list on the NYSE under the symbol GMED. BofA Merrill Lynch, Goldman Sachs, Piper Jaffray and Leerink Swann are the joint bookrunners on the deal.

LegalZoom.com ( LGZ ), a provider of online legal services to consumers and small businesses in the US, plans to raise $88 million by offering 8.0 million shares at a price range of $10.00 to $12.00. At the midpoint of the proposed range, LegalZoom.com would command a market value of $483 million. LegalZoom.com, which was founded in 1999, booked $165 million in sales over the last 12 months. The Glendale, CA-based company plans to list on the NYSE under the symbol LGZ. Morgan Stanley and BofA Merrill Lynch are the joint bookrunners on the deal.

Stemline Therapeutics ( STML ), a biotech developing treatments that target cancer stem cells and tumor bulk, plans to raise $42 million by offering 3.5 million shares at a price range of $11.00 to $13.00. At the midpoint of the proposed range, Stemline Therapeutics would command a market value of $128 million. Stemline Therapeutics was founded in 2003. The New York, NY-based company plans to list on the NASDAQ under the symbol STML. RBC Capital Markets and Oppenheimer & Co. are the joint bookrunners on the deal.

Renaissance Capital will have Pre-IPO Research available on each of these upcoming IPOs prior to its pricing.

Last week, there were 7 IPO pricings . Natural Grocers by Vitamin Cottage ( NGVC ), a western retailer of natural and organic groceries and dietary supplements, was the week's winner, ending up 33% from its IPO price.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: ELOQ , GMED , LGZ , NGVC , STML

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

Most Active by Volume

91,252,153
  • $13.78 ▼ 4.31%
68,133,496
  • $12.93 ▲ 6.77%
57,268,074
  • $46.13 ▲ 2.47%
43,432,023
  • $105.22 ▲ 0.37%
40,880,685
  • $13.46 ▲ 8.90%
40,712,405
  • $98.62 ▲ 0.82%
39,776,976
  • $16.72 ▲ 0.72%
34,688,871
  • $11.16 ▲ 3.05%
As of 10/24/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com